Syndicated Research Studies

The global RNA analysis market was valued at USD 8.62 billion in 2024 and is anticipated to expand to USD 23.65 billion by 2033, registering a compound annual growth rate (CAGR) of 12.55% from 2025 to 2033. Market expansion is primarily supported by the increasing importance of transcriptomic research in precision medicine, continuous advancements in next-generation sequencing (NGS) technologies, and the growing utilization of RNA-based biomarkers in disease diagnosis and pharmaceutical research. The rising focus on early disease detection and targeted therapies has further accelerated the demand for advanced RNA analysis tools and platforms across research and clinical settings. Rapid technological progress has enhanced sequencing accuracy, throughput, and data interpretation, making RNA analysis more accessible to academic institutions, biotechnology firms, and clinical laboratories. In parallel, increased funding for genomics research and expanding applications of RNA profiling in...

Prepare for a scientific revolution! The global RNA analysis market is on a steep ascent, projected to command a colossal USD 20.21 billion by 2030, fueled by an impressive CAGR of 10.86%. This isn't just growth; it's a testament to the transformative power of transcriptomics, a cutting-edge field in the post-genomic era. Unlocking Life's Blueprints: The Power of Transcriptomics The remarkable advancements in this industry stem from the ever-expanding applications of transcriptome sequencing in life sciences, particularly for capturing polyadenylated RNA. With the explosive growth of next-generation high-throughput sequencing technology, our understanding of RNA-based gene regulatory networks is constantly deepening. For instance, in a groundbreaking move in July 2021, a Lithuanian team embarked on developing a novel droplet-based technique to simultaneously capture and sequence both mRNA and microRNA from a single cell—a research endeavor bolstered by a substantial USD ...